Medical research

Revealing a novel mode of action for an osteoporosis drug

(Medical Xpress)—Raloxifene is a U.S. Food and Drug Administration (FDA)-approved treatment for decreasing fracture risk in osteoporosis. While raloxifene is as effective at reducing fracture risk as other current treatments, ...

Immunology

Asthma sufferers may be prone to bone loss

Some of the 26 million Americans with asthma may also be prone to bone loss. According to a study published today in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College ...

Diseases, Conditions, Syndromes

Osteoporosis drugs compared for side effects, efficacy

A study comparing the efficacy and tolerability of two popular osteoporosis drugs, denosumab and zoledronic acid, found that denosumab had a significantly greater effect on increasing spine bone mineral density and zoledronic ...

Diseases, Conditions, Syndromes

Not just a 'women's disease,' osteoporosis strikes men too

Osteoporosis, a disease that causes bones to weaken and sometimes break, is often thought of as a "women's disease," but it poses a significant threat to more than 2 million men in the United States, according to the National ...

Diseases, Conditions, Syndromes

Fat in organs and blood may increase risk of osteoporosis

Excess fat around the belly has recently been identified as a risk factor for bone loss. Now, a new study has determined that excess liver and muscle fat also may be detrimental to bone.

Medical research

Building healthy bones takes guts

(Medical Xpress)—In what could be an early step toward new treatments for people with osteoporosis, scientists at Michigan State University report that a natural probiotic supplement can help male mice produce healthier ...

page 5 from 9